Skip to content

A comparative study on the optimal infusion rate of continuous infusion of norepinephrine for prevention of hypotension after cesarean section in normal and obese women

A comparative study on the optimal infusion rate of continuous infusion of norepinephrine for prevention of hypotension after cesarean section in normal and obese women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115478
Enrollment
Unknown
Registered
2025-12-26
Start date
2024-05-20
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parturients who are scheduled for elective cesarean delivery

Interventions

Normal group 1:Intravenous prophylactic infusion of norepinephrine 0.02 µg/kg/min
Normal group 2:Intravenous prophylactic infusion of norepinephrine 0.03 µg/kg/min
Normal group 3:Intravenous prophylactic infusion of norepinephrine 0.04 µg/kg/min
Normal group 4:Intravenous prophylactic infusion of norepinephrine 0.05 µg/kg/min
Normal group 5:Intravenous prophylactic infusion of norepinephrine 0.06 µg/kg/min
Obesity group 1:Intravenous prophylactic infusion of norepinephrine 0.02 µg/kg/min
Obesity group 2:Intravenous prophylactic infusion of norepinephrine 0.03 µg/kg/min
Obesity group 3:Intravenous prophylactic infusion of norepinephrine 0.04 µg/kg/min
Obesity group 4:Intravenous prophylactic infusion of norepinephrine 0.05 µg/kg/min
Obesity group 5:Intravenous prophylactic infusion of norepinephrine 0.06 µg/kg/min

Sponsors

Women's Hospital School of Medicine Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA grade II, single pregnancy, gestational age >= 37 weeks, BMI >= 30 kg/m^2, or BMI 18.9–24.9 kg/m^2, women aged 18 to 40 undergoing elective cesarean section, including both obese and normal-weight mothers

Exclusion criteria

Exclusion criteria: 1.The contraindications of spinal and epidural anesthesia ; 2. Active stage of labor; 3. placenta previa or other placental abnormalities; 4. multiple pregnancy; 5. Emergency or immediate cesarean section; 6. History of 3 or more cesarean sections; 7. umbilical cord prolapse; 8. Previous history of hypertension, preeclampsia; 9. Patients with a history of norepinephrine allergy; 10, Patients with any cardiovascular system disease; 11. refuse to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
Whether hypotension occurs between spinal anesthesia and fetal delivery;

Secondary

MeasureTime frame
Neonatal outcome;Maternal hemodynamic changes;Maternal adverse reactions;

Countries

China

Contacts

Public ContactXiaowei Qian

Women's Hospital School of Medicine Zhejiang University

qianxw@zju.edu.cn+86 157 0015 7161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026